12-month Primary Endpoint Analysis From The Phase Iii Rop-et Study Of Ropeginterferon Alfa-2b In Et
Synopsis
Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, discusses the 12-month primary ...
You Might Also Like
Download Options
Choose a download method below. All links open in new tabs.
| Service | Features | Action |
|---|---|---|
| SaveFrom |
MP4 & MP3 • HD Quality • Browser Extension Available
|
Download |
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.